🌍 Today, on #WorldCancerDay, we are proud to highlight our collaboration w/ key organisations in the #CardioOnco field
As we continue to advance research & innovation in cardio-oncology
Join us in Florence for #ESCardioOnco2025 bit.ly/4hmiuGx
#ESCCardioOnco
As we continue to advance research & innovation in cardio-oncology
Join us in Florence for #ESCardioOnco2025 bit.ly/4hmiuGx
#ESCCardioOnco
February 4, 2025 at 10:20 AM
🌍 Today, on #WorldCancerDay, we are proud to highlight our collaboration w/ key organisations in the #CardioOnco field
As we continue to advance research & innovation in cardio-oncology
Join us in Florence for #ESCardioOnco2025 bit.ly/4hmiuGx
#ESCCardioOnco
As we continue to advance research & innovation in cardio-oncology
Join us in Florence for #ESCardioOnco2025 bit.ly/4hmiuGx
#ESCCardioOnco
Left ventricular function and its longitudinal change in Swiss childhood cancer survivors - Results from the CardioOnco Study https://www.medrxiv.org/content/10.1101/2025.11.20.25340636v1
November 21, 2025 at 9:56 PM
Left ventricular function and its longitudinal change in Swiss childhood cancer survivors - Results from the CardioOnco Study https://www.medrxiv.org/content/10.1101/2025.11.20.25340636v1
How CHA2DS2-VASc and HAS-BLED scores perform in predicting stroke and bleeding in #afib and cancer?
This and so much more in the #EHJOPen collection on advances in #cardioonco 👉https://ow.ly/6pQ750W76Xk
This and so much more in the #EHJOPen collection on advances in #cardioonco 👉https://ow.ly/6pQ750W76Xk
June 11, 2025 at 1:05 PM
How CHA2DS2-VASc and HAS-BLED scores perform in predicting stroke and bleeding in #afib and cancer?
This and so much more in the #EHJOPen collection on advances in #cardioonco 👉https://ow.ly/6pQ750W76Xk
This and so much more in the #EHJOPen collection on advances in #cardioonco 👉https://ow.ly/6pQ750W76Xk